Blog - Page 581 of 5684 - QualityStocks

MondayDec 18, 2023 1:42 pm

QualityStocksNewsBreaks – SenesTech Inc. (NASDAQ: SNES) Announces Strategic Agreement, Initial Order for Evolve(TM) in Hong Kong and Macau

SenesTech (NASDAQ: SNES), the leader in fertility control to manage animal pest populations, today announced its entry into a distribution agreement with Fruit Tree Limited, a Hong Kong-based pest control service provider, manufacturer and distributor. SenesTech is in the process of commercializing a proprietary technology for managing animal pest populations, primarily rat populations, through fertility control. The agreement with Fruit Tree Limited includes both a substantial initial stocking order and annual minimums. “Fruit Tree Ltd. is a leading company in the pest control industry, supplying products and services throughout the region, directly and through its subsidiaries, with a commitment to…

MondayDec 18, 2023 1:37 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces DSMB Recommendation to Continue Pivotal GBM Study without Modification

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, announced a recommendation from the independent Data Safety Monitoring Board (“DSMB”) regarding Berubicin, the company’s investigational agent. According to the announcement, the DSMB recommends that CNS Pharmaceuticals’ ongoing global, potentially pivotal trial of Berubicin for the treatment of glioblastoma multiforme (“GBM”) continue without modification. The company also noted that it anticipated enrollment for the trial to be complete in the first quarter of 2024. The Berubicin study is a multicenter, open-label, randomized controlled study…

MondayDec 18, 2023 12:06 pm

QualityStocksNewsBreaks – HUB Cyber Security Ltd. (NASDAQ: HUBC) Expands Partnership with Global Entertainment Entity

HUB Cyber Security (NASDAQ: HUBC), a developer of confidential computing cybersecurity solutions and services is expanding its collaboration with a top global entertainment company; the expansion reflects the success of the ongoing partnership, the company noted. According to the announcement, the expansion includes the entertainment company integrating HUB Security's cybersecurity services across its global branches in order to fortify digital infrastructure and enhance protection against emerging cybersecurity threats. “We are excited to enhance our partnership with a renowned leader in the entertainment industry,” said HUB Cyber Security CEO Noah Hershcoviz in the press release. “This development is a testament to…

MondayDec 18, 2023 12:02 pm

QualityStocksNewsBreaks – Appia Rare Earths & Uranium Corp. (CSE: API) (OTCQX: APAAF) (FSE: A0I0) Launches Redesigned Corporate Website

Appia (CSE: API) (OTCQX: APAAF) (FSE: A0I0) today unveiled its new corporate website, which better presents project milestones and company information. The newly designed site includes a dedicated projects landing page, updated corporate presentation and fact sheet that prominently highlights the substantial strides Appia has made on its rare earth element (“REE”) and uranium projects in Canada and REE Ionic Adsorption Clay (“IAC”) project in Brazil, providing insights into both current and historical endeavors. “Our website redesign is not just about aesthetics; it’s a window into the depth of our commitment and progress,” said Tom Drivas, CEO of Appia Rare…

MondayDec 18, 2023 10:51 am

QualityStocksNewsBreaks – Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) Reports ‘Encouraging’ Results from Definition Drill Program at Iska Iska Project

Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM), a leading exploration and mine development company, is reporting on the first assay results from five of the 11 drill holes in its current definition drill program at the Iska Iska silver-tin polymetallic project, which is situated in southwestern Bolivia. According to the announcement, the drill hole results are “most encouraging” because they demonstrate substantive higher-grade intervals, especially for silver, in the potential starter pit mineral resource area, which may now be potentially upgraded and expanded. The definition diamond drill program is focused on upgrading and expanding the higher-grade Polymetallic (“Ag-Zn-Pb”) Domain Type inferred…

MondayDec 18, 2023 10:38 am

QualityStocksNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Announces Adjournment of Special Meeting

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, adjourned its Special Meeting of Stockholders, which convened on Dec. 15, 2023; the meeting is slated to begin today at 9:30 a.m. PT. According to the announcement, the decision to adjourn the meeting was made to provide time to solicit proxies regarding a proposal that had been submitted to stockholders for approval. The company noted that the proposal, Proposal 1, seeks stockholder approval to amend the company’s certificate of incorporation to effect a reverse stock split of MULN’s outstanding common stock at an exchange ratio between 1-for-2 to 1-for-100; the specific…

MondayDec 18, 2023 10:30 am

How Clene Inc. (NASDAQ: CLNN) CNM-Au8(R) Takes Advantage of Gold Nanocrystals to Target Neurodegenerative Disorders

Clene, a late clinical-stage biopharmaceutical company, creates clean-surfaced, catalytically active nanocrystals that directly modulate biological systems, including the central nervous system, by improving mitochondrial health The company’s lead investigational candidate, CNM-Au8(R), is currently in development as a disease-modifying treatment for people living with specific types of neurodegenerative disorders (“ND”), namely amyotrophic lateral sclerosis (“ALS”), Parkinson’s Disease, and multiple sclerosis (“MS”) Neurodegenerative disorders are characterized by neurodegeneration – the progressive loss of neuron structure, neuronal functions, and finally, the neurons themselves Nanotherapeutics are in development to stop or reverse neurodegeneration using novel approaches to address the mitochondrial deficits and bioenergetic crises…

MondayDec 18, 2023 9:45 am

PaxMedica Inc. (NASDAQ: PXMD) Fireside Chat with CEO Howard Weisman Sheds Light on Company Achievements for ASD Therapy Pipeline

The CDC estimates 1 out of 36 children in the United States have been diagnosed with Autism Spectrum Disorder – with a therapeutic market potential of $3.42 billion by 2030 PaxMedica’s mission is to help eliminate, reduce, or modulate the troublesome aspects of ASD, an unmet medical need in the industry CEO Howard Weisman shared important updates and achievements in the company’s pipeline, financial outlook, and future vision In a 2020 report released by the Centers for Disease Control and Prevention (“CDC”), it was estimated that 1 out of 36 children had been diagnosed with autism spectrum disorder (“ASD”) in…

MondayDec 18, 2023 9:00 am

GEMXX Corp. (GEMZ) Reports Rise in Earnings, Assets, and Income in 2023, Prepares for Further Strategic Growth in Coming Year

GEMXX Corporation is a Las Vegas-based jewelry maker developing its strategic gold metal and ammolite gemstone from a unique mine-to-market product pipeline Gold has enjoyed record high prices during a “roaring 2023” run, and price fluctuations surrounding those highs have failed to deter optimism that demand for the precious metal may remain during the coming year GEMXX is the only publicly traded ammolite gemstone company in the world, and plans to expand its gemstone and jewelry production by 300 percent next year The company reported upbeat earnings and no long-term debt in its recent Q2 financial statement With the close…

FridayDec 15, 2023 3:45 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Targeting New and More Lucrative Global Markets

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, is exploring the impact of its patented DehydraTECH(TM) technology on the oral performance of GLP-1 drugs for the treatment of diabetes and weight loss. “The move could help Lexaria carve out an important market share for an industry that is projected to bring in between $150 billion and $200 billion a year. Given the positive results the company has achieved so far in its diabetes and hypertension clinical studies, Lexaria is optimistic that its foray into GLP-1 drugs will yield positive results and open up its technology to…

Site Search

Company Search